Main Menu

Our Work

Innovative medicine patent policy in India

Prepared a white paper for the National Association of Manufacturers (NAM) to evaluate restrictive trade policies in place in India, among which is failure to grant patents on innovative medicines. The report accompanies NAM’s submission to the United States International Trade Commission which is conducting an investigation into trade and industrial policies in India as they affect the US economy.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.